Sean F. Scanlan

Sean F. Scanlan

Chief Innovation OfficeratTreace Medical Concepts· In proxies 2022–2025

Pay in FY2025-25% from the year before · Treace Medical Concepts stock -67.1% the same year

Sean F. Scanlan was paid $2.3M in FY2025 (Dec), down 25%. Treace Medical Concepts stock fell 67.1% that year.

Pay$100 in the stock at the end of FY21 → $13
Pay is from the Summary Compensation Table of each Treace Medical Concepts proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Treace Medical ConceptsPublic company · 4 yr
    • Chief Innovation Officer2022 – Present · 4 yrStock in role -72%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?